Aller au contenu principal
Faslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer  Faslodex (Fulvestrant) - Macrocare Health Blog

Faslodex (Fulvestrant) 250 mg – Hormonal Therapy for Breast Cancer Faslodex (Fulvestrant)

Faslodex (Fulvestrant) is a hormonal therapy used in the treatment of HR-positive breast cancer, particularly in advanced or metastatic cases. It helps slow the growth of cancer cells that depend on estrogen.

 

What is Faslodex (Fulvestrant)?

Faslodex belongs to a class of drugs known as Estrogen Receptor Antagonists.

Some types of breast cancer rely on estrogen to grow and spread. Faslodex works by:

  • Blocking estrogen receptors in cancer cells
  • Reducing the effect of estrogen on tumors
  • Slowing cancer growth and progression

In simple terms:
It prevents cancer cells from using estrogen to grow.

 

Indications

Faslodex (Fulvestrant) is used in:

  • HR-positive breast cancer
  • Advanced or metastatic disease
  • Cases previously treated with hormonal therapy
  • Combination therapy with targeted agents such as CDK4/6 inhibitors
 

Dosage and Administration

  • Standard dose: 250 mg or according to treatment protocol
  • Administered as an intramuscular injection
  • Injection schedule is determined by the physician
  • May be used alone or in combination with other therapies
 

Common Side Effects

May include:

  • Injection site pain
  • Hot flashes
  • Nausea
  • Fatigue
  • Joint or muscle pain
  • Headache

These side effects are usually manageable with proper monitoring.

 

Monitoring During Treatment

Patients on Faslodex (Fulvestrant) require:

  • Assessment of tumor response
  • Symptom evaluation
  • Liver function monitoring when needed
  • Regular imaging and follow-up examinations
 

Availability & How to Access Treatment

Faslodex (Fulvestrant) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

 

Faslodex (Fulvestrant) Faslodex (Fulvestrant) 250 mg is an effective hormonal therapy that helps slow the progression of HR-positive breast cancer by blocking estrogen activity in cancer cells.

 

Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

 
 

Autres articles

Saisir le numéro de mobile

Veuillez indiquer votre numéro de téléphone afin que nous puissions vous contacter pour en savoir plus sur votre problème de santé.

Confidentialité protégée : vos informations médicales et personnelles restent entièrement confidentielles et sécurisées grâce à une protection conforme aux normes du secteur.

CONTACTEZ-NOUS

Contactez-nous

Veuillez indiquer votre numéro de téléphone afin que nous puissions vous contacter pour en savoir plus sur votre problème de santé.

Ligne directe

+20 106 604 2282

Appeler

Adresse e-mail

[email protected]

Écrire